目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 BREAKDOWN OF PRIMARIES
2.1.2.3 KEY INDUSTRY INSIGHTS
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 SCOPE-RELATED LIMITATIONS
2.7.2 METHODOLOGY-RELATED LIMITATIONS
2.8 RECESSION IMPACT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ADHESION BARRIER: MARKET OVERVIEW
4.2 APAC: ADHESION BARRIER MARKET , BY TYPE
4.3 ADHESION BARRIER MARKET: GEOGRAPHIC MIX
4.4 ADHESION BARRIER MARKET , BY REGION (2023-2028)
4.5 ADHESION BARRIER MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 INDUSTRY TRENDS
5.4 REGULATORY LANDSCAPE
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.4.2 REGULATORY ANALYSIS
5.5 KEY CONFERENCES & EVENTS IN 2022-2023
5.6 SUPPLY CHAIN ANALYSIS
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM MARKET MAP
5.9 PORTER’S FIVE FORCES ANALYSIS
5.10 PATENT ANALYSIS
5.11 TECHNOLOGY ANALYSIS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.12.2 AVERAGE SELLING PRICE TREND, BY FORMULATION
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 TRADE ANALYSIS

6 ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
6.1 INTRODUCTION
6.2 SYNTHETIC PRODUCTS
6.2.1 HYALURONIC ACID
6.2.2 REGENERATED CELLULOSE
6.2.3 POLYETHYLENE GLYCOL
6.2.4 OTHER SYNTHETIC ADHESION BARRERS
6.3 NATURAL PRODUCTS

7 ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
7.1 INTRODUCTION
7.2 FILM FORMULATIONS
7.3 GEL FORMULATIONS
7.4 LIQUID FORMULATIONS

8 ADHESION BARRIER MARKET, BY APPLICATION AREA/SURGICAL PROCEDURE, 2021-2028 (USD MILLION)
8.1 INTRODUCTION
8.2 GYNECOLOGICAL SURGERIES
8.3 GENERAL/ABDOMINAL SURGERIES
8.4 ORTHOPEDIC SURGERIES
8.5 CARDIOVASCULAR SURGERIES
8.6 NEUROLOGICAL SURGERIES
8.7 UROLOGICAL SURGERIES
8.8 RECONSTRUCTIVE SURGERIES
8.9 OTHER SURGERIES

9 ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
9.1 INTRODUCTION
9.2 HOSPITALS AND CLINICS
9.3 AMBULATORY SURGICAL CENTERS
9.4 OTHER END USERS

10 ADHESION BARRIER MARKET, BY REGION, 2021-2028 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT
10.2.2 US
10.2.3 CANADA
10.3 EUROPE
10.3.1 RECESSION IMPACT
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 UK
10.3.5 ITALY
10.3.6 SPAIN
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT
10.4.2 JAPAN
10.4.3 CHINA
10.4.4 INDIA
10.4.5 AUSTRALIA
10.4.6 SOUTH KOREA
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 RECESSION IMPACT
10.5.2 BRAZIL
10.5.3 MEXICO
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022)
11.3 COMPANY FOOTPRINT ANALYSIS
11.4 COMPANY EVALUATION MATRIX
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
11.5 STARTUPS/SMES EVALUATION QUADRANT (2023)
11.5.1 PROGRESSIVE COMPANIES
11.5.2 STARTING BLOCKS
11.5.3 RESPONSIVE COMPANIES
11.5.4 DYNAMIC COMPANIES
11.6 COMPETITVE BENCHMARKING
11.7 MARKET SHARE ANALYSIS, BY KEY PLAYERS (2022)
11.8 COMPETITIVE SITUATION & TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS

12 COMPANY PROFILES
(Business Overview, Financials, Recent Developments, MnM View)
12.1 KEY PLAYERS
12.1.1 JOHNSON & JOHNSON
12.1.2 BAXTER INTERNATIONAL
12.1.3 BECTON, DICKINSON, AND COMPANY
12.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
12.1.5 ANIKA THERAPEUTICS
12.1.6 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP)
12.1.7 FZIOMED
12.1.8 MAST BIOSURGERY
12.1.9 WL GORE & ASSOCIATES
12.1.10 GUNZE LIMITED
12.2 OTHER PLAYERS
12.2.1 CORMATRIX
12.2.2 TERUMO CORPORATION
12.2.3 BIOSCOMPASS
12.2.4 SEIKAGAKU CORPORATION
12.2.5 ALLOSOURCE
12.2.6 XLYNK SURGICAL
12.2.7 LUNA INNOVATIONS
12.2.8 ACTAMAX
12.2.9 ARC MEDICAL DEVICES
12.2.10 CGBIO
12.2.11 INNOCOLL HOLDINGS
12.2.12 BETATECH MEDICAL
12.2.13 LEADER BIOMEDICAL
12.2.14 PLANTTEC MEDICAL GMBH
12.2.15 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO.,LTD

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS